Single-use Bioreactors Market Trends

Single-use Bioreactors Market Trends

Increasing focus of the U.S. FDA and researchers on rare disease therapies have significantly increased the number of novel therapies in recent time. Growing scientific advances such as genetics and the application of next generation therapeutic approaches such as use of biomarkers is propelling the demand for orphan therapies.
 

• Orphan drugs are generally classified as those medicines that fall under one or more medicines approved under the Orphan Drug Act. Increasing use of orphan drugs in various clinical applications and increasing number of FDA approvals are the factors contributing to the drug development.
   
• Moreover, increasing use of orphan drugs in rare diseases and presence of large FDA approved drugs are also augmenting the sales of orphan drugs. In 2020, nearly 32 novel drugs along with biologics designated as orphan drugs were approved by the U.S. FDA. Thus, with development and growing demand for orphan drugs, the requirement of bioreactor systems will expand in upcoming years.